VERA THERAPEUTICS INC (VERA) Stock Income Statement
NASDAQ:VERA - Nasdaq - US92337R1014 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 193.25M | 167.17M | 102.01M | 90.90M | 34.40M | |||
| Research and Development | 144.25M | 126.17M | 78.22M | 68.99M | 22.48M | |||
| Selling, General, and Administrative Expenses | 49.00M | 41.00M | 23.79M | 21.91M | 11.92M | |||
| Operating Income | -193.25M | -167.17M | -102.01M | -90.90M | -34.40M | |||
| Interest Income/Expense | 15.92M | 13.09M | 4.19M | 760.00K | -10.00K | |||
| Other Income/Expense | 1.87M | 1.94M | 1.83M | 1.09M | -890.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | 2.69M | |||
| Income Before Taxes | -175.46M | -152.15M | -95.99M | -89.06M | -32.61M | |||
| Income Tax | N/A | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Net Income | -175.46M | -152.15M | -95.99M | -89.06M | -32.61M | |||
| EBITDA | -193.06M | -167.06M | N/A | N/A | -34.22M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.99 | -2.75 | -2.25 | -3.35 | -1.53 | |||
| Non GAAP EPS | -3.00 | -2.75 | -2.31 | -3.35 | -13.71 | |||
| Statistics | ||||||||
All data in USD